Early-onset Alzheimer’s disease progresses more rapidly and often strikes people in the prime of their lives. A new treatment ...
But new data from a recent clinical trial suggests that a previously discontinued experimental drug, called gantenerumab, ...
Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and ...
Alzheimer's disease is usually associated with old age. But around 5%-10% of all Alzheimer's cases occur in people under the age of 65. Early-onset ...
Study participants in GRADUATE 1 and 2 treated with gantenerumab showed a slowing of clinical decline of -0.31 and -0.19 from baseline score, respectively, on the Clinical Dementia Rating-Sum of ...
Alzheimer's treatment may lie in the brain's own cleanup crew: Harnessing microglia to clear plaques
But not all microglia are created equal. Some are quite effective at removing plaques, while others struggle, the study found. Also, microglia in treated brains adopt distinct states depending on ...
University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's disease were in a pre-inflammatory state more frequently, making them less ...
Glenmark Pharmaceuticals, an India-based drug manufacturer has issued a voluntary recall affecting nearly 1.48 million bottles of atomoxetine, a generic medication used to treat ADHD. The recall ...
A well-known antimalaria therapy could be repurposed to kill cancer cells, according to researchers at The University of Texas at El Paso. The medication is pyronaridine, which has been used for ...
Glia are essential for brain functioning during development and in the adult brain. Here, we discuss the various roles of both microglia and astrocytes, and their interactions during brain development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results